Pharmacology and the Liver

Last Updated: 1 August 2017

The interface of drugs and the liver is multifaceted and key to understanding three important areas of pharmacology, systemic drug exposure, a major type of drug toxicity, and the pharmacology of drugs that have the liver as a therapeutic target.  This issue of Pharmacology Research & Perspectives has assembled papers recently published in scheduled issues of the Journal that address all three of these areas.  Potential treatments to protect hepatic function during disease or toxin exposures are evaluated.  Methods to evaluate the hepatotoxic potential of drugs are described.  With respect to systemic drug exposure, several papers that characterize hepatic drug metabolism and drug-drug interactions provide essential data to understand liver related determinants of drug disposition.  This issue highlights rigorously reviewed contributions to the literature to further the methodology and understanding of liver related pharmacology.

Darrell R. Abernethy

Editor-in-Chief



Andrew J. Lawrence

Deputy Editor
Brief Detailed

In Memoriam: Darrell R. Abernethy, M.D. Ph.D.

It is with deep sadness that the Editorial Team at PR&P must convey the news that Darrell Abernethy, Editor in Chief of the Journal, has recently passed away. Darrell has been instrumental in raising the profile and quality of PR&P in both his roles on the Journal, first as Deputy Editor and then Editor. He has been a true inspiration to so many of our authors and editors who work in the field of pharmacology, very much a team player, providing considered and thoughtful responses. His wise counsel will be missed.

Rest in peace

PR&P Editorial Team

Darrell's obituary can be viewed on the ASPET website